Panacea Biotec Limited has informed the Exchange regarding Resignation of Mr CA Rajesh Jain as Non- Executive Independent Director of the company w.e.f. Jun 30, 2026.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec Limited has informed stock exchanges that CA Rajesh Jain (DIN: 10619014), a Non-Executive Independent Director, has tendered his resignation effective close of business hours on June 30, 2026. He is also stepping down from the board of the company's material wholly-owned subsidiary, Panacea Biotec Pharma Limited. His reason cited is increasing professional commitments and the time demands of evolving regulatory and corporate governance requirements, which he says prevent him from devoting adequate attention to the role. He will also vacate his chairmanship/membership of all board committees, including the Audit Committee and Nomination & Remuneration Committee. The filing notes that the resigning director shares the same name as the company's Chairman and Managing Director, Dr. Rajesh Jain, and confirms there are no other material reasons for the resignation.
This is a routine, pre-scheduled independent director exit with a clear, non-controversial reason and a 3-month transition period until June 30, 2026. The company will need to appoint a replacement independent director in due course to maintain board composition norms, but no immediate negative implication for shareholders is evident from this disclosure.